Breaking Finance News

Barclays Capital announced Healthways (NASDAQ:HWAY), bumping its price target to $27.00 earlier today

Healthways (NASDAQ:HWAY) had its estimated target price increased to $27 by Barclays Capital in a report announced Monday August 22 2016. The latest target price indicates a possible upside of 0.08% based on the bussiness’ last closing price.

Previously on 8/12/2016, FBR Capital reported about Healthways(NASDAQ:HWAY) bumped the target price from $21.00 to $28.00. At the time, this suggested an upside of 0.24%.

Having a price of $24.90, Healthways (NASDAQ:HWAY) traded 1.18% higher on the day. With the last close up 76.76% from the two hundred day average, compared to the S&P 500 Index which has fallen -0.01% over the same time. HWAY has registered a 50-day moving average of $21.91 and two hundred day average of $14.12. 572,865 shares of the stock traded, down from ann avg. trading volume of 708,248

Recent Performance Graph:

Healthways (NASDAQ:HWAY)

Healthways has a one-year low of $9.18 and a one-year high of $26.00. The company’s total market value is currently $0.0.

A total of 6 equity analysts have released a research note on the stock. Two firms rate the stock a strong buy, one analyst rate the company a buy, four firms rate the company a hold, one brokerage rate the stock to underperform, and lastly 0 firmsrate the stock as sell with a 12-month target stock price of $13.50

More About Healthways (NASDAQ:HWAY)

Healthways, Inc. (Healthways) provides network delivered solutions and population health management services that are designed to help people manage their wellbeing, thereby managing their health and productivity, and their health-related costs. The Company operates in the domestic and international segments, which are collectively known as the well-being improvement services segment. The Company engages entire populations, including health plan memberships, workforces and communities, while in other cases it engages targeted populations, such as members at high-risk, cohorts of cardiac rehabilitation patients or hospital discharge patients. In the United States, it operates in approximately 50 states and the District of Columbia. Its customers include health plans, both commercial and Medicare Advantage, large self-insured employers, including state and municipal government entities, and providers of healthcare, including integrated healthcare systems, and and hospitals.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.